Prospects for immunological control of schistosomiasis (Q40538544)

21 September 2017

1 reference

title

Prospects for immunological control of schistosomiasis (English)

1 reference

21 September 2017

0 references

1

1 reference

21 September 2017

P Hagan

2

0 references

author name string

F G Abath

series ordinal

3

1 reference

PubMed ID

7769906

21 September 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

21 September 2017

1 reference

21 September 2017

345

1 reference

21 September 2017

8963

1 reference

21 September 2017

1488-1491

1 reference

The Organization of schistosomiasis control programmes

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Vaccines against schistosomiasis: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Resistance to reinfection after treatment of urinary schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Immunoglobulin E and effector cells in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Antibody isotype responses to the Schistosoma mansoni schistosomulum in the CBA/N mouse induced by different stages of the parasite life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Human antibody responses to Schistosoma mansoni: the influence of epitopes shared between different life-cycle stages on the response to the schistosomulum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Immunity to schistosomes: progress toward vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Mr 26,000 antigen of Schistosoma japonicum recognized by resistant WEHI 129/J mice is a parasite glutathione S-transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Cloning and sequence analysis of the Schistosoma mansoni membrane glycoprotein antigen gene GP22.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

A cDNA clone encoding part of the major 25,000-dalton surface membrane antigen of adult Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Structure of Sm25, an antigenic integral membrane glycoprotein of adult Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Molecular cloning of a protective antigen of schistosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Prospects for a nonliving vaccine against schistosomiasis based on cell-mediated immune resistance mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Paramyosin and actin in schistosomal teguments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Schistosoma mansoni: induction of protective immunity in rats using a recombinant fragment of a parasite surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Cloning and sequencing of a complete myosin heavy chain cDNA from Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Antischistosomal vaccines: beyond the laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

Quantitative determination of circulating soluble egg antigen in urine and serum of Schistosoma mansoni-infected individuals using a combined two-site enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991041-7

7 January 2021

10.1016/S0140-6736(95)91041-7

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7769906